LINC01133 and metastatic malignant neoplasm in the lymph nodes: As shown in Table 1, there is a significant association between decreased expression of LINC01133 and stage IV LSCC (p=0.0206) (Fig. 2C) as well as the presence of lymph node metastasis (p=0.0203) (Fig. 2D).